NEW YORK, Aug. 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially...
Related Questions
What precedent do similar securities classâaction cases have on settlement timing and magnitude, and how might that influence market perception of WGS?
What are the potential shortâterm price impacts and volatility expectations for WGS following this classâaction investigation announcement?
How likely is a material adverse effect on GeneDx's revenue or product pipeline due to the alleged securities misstatements?